Take Solutions to buy US firms for $72 million to scale up global footprint

By: | Published: January 12, 2019 3:48 AM

Take Solutions, the Chennai-based company, which offers domain-intensive services in life sciences and supply chain management has announced that it has proposed to acquire two US-based companies.

The total consideration for the 100% buyout of KAI Research would be to the tune of million while DataCeutics will be cent per cent acquired, for a consideration of million.

Take Solutions, the Chennai-based company, which offers domain-intensive services in life sciences and supply chain management, on Friday announced that it has proposed to acquire two US-based companies, namely KAI Research and DataCeutics, for a total consideration of $72 million.

While KAI is a niche full service clinical research organisation (CRO) and health research company, DataCeutics is a specialty clinical details functional service provider. The total consideration for the 100% buyout of KAI Research would be to the tune of $27 million while DataCeutics will be cent per cent acquired, for a consideration of $45 million.

ALSO READ: GST Council meeting: Here is list of 5 key decisions taken by Modi govt

In a regulatory filing to the stock exchanges, Take Solutions said since KAI has been in life sciences industry, with this acquisition, it will possess Phase-II and Ill capabilities in North America, adding to its current service offerings in Europe and Asia.

“The company (KAI) has some differentiated offerings by way of patient registries and e-clinical solutions. KAI strengthens our therapeutic expertise, and offerings on mental health, musculoskeletal diseases, infectious diseases, oncology and medical devices. KAI has long-standing relationships with clinical sites and trusted network of service providers,” Take Solutions said.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition